What Happened?
, -based MBX Biosciences Appointed Richard Bartram as CFO
About the Company
MBX Biosciences is a preclinical-stage biotechnology company using validated molecular targets to create medicines for rare endocrine diseases where current therapies are inadequate.
About the Person
Richard Bartram is CFO at MBX Biosciences. Previously, Richard held various senior HR leadership roles in the industry.
Info Source
News
Short Profile